Tsi, Llc

Website Links

Description

Alexis Wallace, President and Chief Executive Officer, co-founder Mr. Alexis Wallace is President, Chief Executive Officer and co-founder of Thrombolytic Science International, a start-up cardiovascular biotechnology company in Cambridge, MA. Mr. Wallace has over fifteen years of international business development and operational experience including a decade with leading biopharmaceutical companies. Most recently, Mr. Wallace was the Executive Director of Medicine in Need, a biotechnology company funded by the Bill and Melinda Gates Foundation. There, Mr. Wallace oversaw the development of an inhaled version of an anti-tuberculosis drug from pre- IND through early human clinical development. Previously, Mr. Wallace was a Principal at Puretech Development, a strategic advisory and partnering group, part of Puretech Ventures. Mr. Wallace created and grew Puretech Development’s European business, advising client CEOs and board of directors on business strategy while leading business development activities in the fields of cardiovascular, drug delivery, ophthalmology and CNS. Mr. Wallace was also Director of Science Strategy at Genzyme Corporation, where he was instrumental in the establishment of major corporate joint ventures resulting recently in commercialized products, Myozyme

Products & services

Similar companies nearby